BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10661406)

  • 1. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection.
    Kanazawa S; Okamoto T; Peterlin BM
    Immunity; 2000 Jan; 12(1):61-70. PubMed ID: 10661406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of class II trans-activator function by HIV-1 tat in mouse cells is independent of competition for binding to cyclin T1.
    Mudhasani R; Fontes JD
    Mol Immunol; 2002 Jan; 38(7):539-46. PubMed ID: 11750655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinations of dominant-negative class II transactivator, p300 or CDK9 proteins block the expression of MHC II genes.
    Kanazawa S; Peterlin BM
    Int Immunol; 2001 Jul; 13(7):951-8. PubMed ID: 11431425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
    Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
    Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal modulation of transcriptional activities between HIV-1 Tat and MHC class II transactivator CIITA.
    Okamoto H; Asamitsu K; Nishimura H; Kamatani N; Okamoto T
    Biochem Biophys Res Commun; 2000 Dec; 279(2):494-9. PubMed ID: 11118314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate.
    Ramanathan Y; Reza SM; Young TM; Mathews MB; Pe'ery T
    J Virol; 1999 Jul; 73(7):5448-58. PubMed ID: 10364292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression.
    Fujinaga K; Irwin D; Geyer M; Peterlin BM
    J Virol; 2002 Nov; 76(21):10873-81. PubMed ID: 12368330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat.
    Fujinaga K; Cujec TP; Peng J; Garriga J; Price DH; Graña X; Peterlin BM
    J Virol; 1998 Sep; 72(9):7154-9. PubMed ID: 9696809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory functions of Cdk9 and of cyclin T1 in HIV tat transactivation pathway gene expression.
    Romano G; Kasten M; De Falco G; Micheli P; Khalili K; Giordano A
    J Cell Biochem; 1999 Dec; 75(3):357-68. PubMed ID: 10536359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription.
    O'Keeffe B; Fong Y; Chen D; Zhou S; Zhou Q
    J Biol Chem; 2000 Jan; 275(1):279-87. PubMed ID: 10617616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hexim1 sequesters positive transcription elongation factor b from the class II transactivator on MHC class II promoters.
    Kohoutek J; Blazek D; Peterlin BM
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17349-54. PubMed ID: 17088550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function.
    Liou LY; Herrmann CH; Rice AP
    J Virol; 2002 Nov; 76(21):10579-87. PubMed ID: 12368300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human I-mfa domain-containing protein, HIC, interacts with cyclin T1 and modulates P-TEFb-dependent transcription.
    Young TM; Wang Q; Pe'ery T; Mathews MB
    Mol Cell Biol; 2003 Sep; 23(18):6373-84. PubMed ID: 12944466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.
    Zhou Q; Chen D; Pierstorff E; Luo K
    EMBO J; 1998 Jul; 17(13):3681-91. PubMed ID: 9649438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter.
    Fong YW; Zhou Q
    Mol Cell Biol; 2000 Aug; 20(16):5897-907. PubMed ID: 10913173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner.
    Michels AA; Nguyen VT; Fraldi A; Labas V; Edwards M; Bonnet F; Lania L; Bensaude O
    Mol Cell Biol; 2003 Jul; 23(14):4859-69. PubMed ID: 12832472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1).
    Chiu YL; Cao H; Jacque JM; Stevenson M; Rana TM
    J Virol; 2004 Mar; 78(5):2517-29. PubMed ID: 14963154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase.
    Chen D; Zhou Q
    Mol Cell Biol; 1999 Apr; 19(4):2863-71. PubMed ID: 10082552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription.
    Barboric M; Yik JH; Czudnochowski N; Yang Z; Chen R; Contreras X; Geyer M; Matija Peterlin B; Zhou Q
    Nucleic Acids Res; 2007; 35(6):2003-12. PubMed ID: 17341462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.